Assignee
AMBRX INC
US·69 granted patents·45 pending applications·1,358 citations·filing 2004–2024
Top patents by PatentIndex Score
114 records- 0199US7820766B2Branched acetylene-containing poly(alkylene oxides, oxyethylated polyols or olefinic alcohols)AMBRX INC·Filed 2010·Granted Oct 26, 2010·26 cites·2 claims
- 0299US7696312B2Compositions containing, methods involving, and uses of non-natural amino acids and polypeptidesAMBRX INC·Filed 2007·Granted Apr 13, 2010·63 cites·17 claims
- 0399US7638491B2Therapies using non-natural amino acids and polypeptidesAMBRX INC·Filed 2005·Granted Dec 29, 2009·40 cites·6 claims
- 0499US7385028B2Derivatization of non-natural amino acids and polypeptidesAMBRX INC·Filed 2005·Granted Jun 10, 2008·91 cites·20 claims
- 0599US7332571B2Compositions containing, methods involving, and uses of non-natural amino acids and polypeptidesAMBRX INC·Filed 2005·Granted Feb 19, 2008·101 cites·6 claims
- 0698US8053560B2Modified human plasma polypeptide or Fc scaffolds and their usesAMBRX INC·Filed 2007·Granted Nov 8, 2011·40 cites·5 claims
- 0798US8012931B2Modified FGF-21 polypeptides and their usesAMBRX INC·Filed 2008·Granted Sep 6, 2011·76 cites·52 claims
- 0898US8008456B2Compositions containing, methods involving, and uses of non-natural amino acids and polypeptidesAMBRX INC·Filed 2007·Granted Aug 30, 2011·28 cites·8 claims
- 0998US7919591B2Modified human plasma polypeptide or Fc scaffolds and their usesAMBRX INC·Filed 2007·Granted Apr 5, 2011·41 cites·1 claims
- 1098US7737226B2Acetylene group-containing poly(alkylene oxide, oxyethylated polyol or olefinic alcohol)AMBRX INC·Filed 2007·Granted Jun 15, 2010·26 cites·20 claims
- 1197US8367612B2Compositions containing, methods involving, and uses of non-natural amino acids and polypeptidesAMBRX INC·Filed 2009·Granted Feb 5, 2013·14 cites·6 claims
- 1297US8048988B2Compositions containing, methods involving, and uses of non-natural amino acids and polypeptidesAMBRX INC·Filed 2007·Granted Nov 1, 2011·28 cites·10 claims
- 1397US8008428B2Azide- or acetylene-terminated poly(alkylene oxide, oxyethylated polyol or olefinic Alcohol)AMBRX INC·Filed 2007·Granted Aug 30, 2011·21 cites·8 claims
- 1497US7928163B2Compositions containing, methods involving, and uses of non-natural amino acids and polypeptidesAMBRX INC·Filed 2007·Granted Apr 19, 2011·31 cites·12 claims
- 1597US7883866B2Compositions of aminoacyl-tRNA synthetase and uses thereofAMBRX INC·Filed 2010·Granted Feb 8, 2011·29 cites·14 claims
- 1697US7829310B2Compositions of aminoacyl-tRNA synthetase and uses thereofAMBRX INC·Filed 2010·Granted Nov 9, 2010·29 cites·19 claims
- 1797US7632924B2Antigen-binding polypeptides and their usesAMBRX INC·Filed 2005·Granted Dec 15, 2009·79 cites·8 claims
- 1897US7230068B2Polymer derivativesAMBRX INC·Filed 2004·Granted Jun 12, 2007·45 cites·51 claims
- 1996US10253083B2Therapeutic uses of modified relaxin polypeptidesAMBRX INC·Filed 2016·Granted Apr 9, 2019·11 cites·20 claims
- 2096US8383365B2Methods of making FGF-21 mutants comprising non-naturally encoded phenylalanine derivativesAMBRX INC·Filed 2011·Granted Feb 26, 2013·48 cites·60 claims
- 2196US8022186B2Modified human plasma polypeptide or Fc scaffolds and their usesAMBRX INC·Filed 2007·Granted Sep 20, 2011·20 cites·5 claims
- 2296US7947473B2Methods for expression and purification of pegylated recombinant human growth hormone containing a non-naturally encoded keto amino acidAMBRX INC·Filed 2008·Granted May 24, 2011·25 cites·4 claims
- 2396US7888533B2Accelerants for the modification of non-natural amino acids and non-natural amino acid polypeptidesAMBRX INC·Filed 2007·Granted Feb 15, 2011·35 cites·10 claims
- 2496US7858344B2Compositions of aminoacyl-tRNA synthetase and uses thereofAMBRX INC·Filed 2010·Granted Dec 28, 2010·20 cites·19 claims
- 2596US7846689B2Compositions of aminoacyl-tRNA synthetase and uses thereofAMBRX INC·Filed 2010·Granted Dec 7, 2010·22 cites·14 claims
- 2696US7838265B2Compositions of aminoacyl-tRNA synthetase and uses thereofAMBRX INC·Filed 2010·Granted Nov 23, 2010·26 cites·14 claims
- 2796US7638299B2Biosynthetic polypeptides utilizing non-naturally encoded amino acidsAMBRX INC·Filed 2005·Granted Dec 29, 2009·63 cites·11 claims
- 2895US10751391B2Methods of treatment using modified relaxin polypeptides comprising a non-naturally encoded amino acidAMBRX INC·Filed 2019·Granted Aug 25, 2020·6 cites·24 claims
- 2995US7816320B2Formulations of human growth hormone comprising a non-naturally encoded amino acid at position 35AMBRX INC·Filed 2005·Granted Oct 19, 2010·40 cites·18 claims
- 3095US7736872B2Compositions of aminoacyl-TRNA synthetase and uses thereofAMBRX INC·Filed 2005·Granted Jun 15, 2010·31 cites·20 claims
- 3195US7468458B2Accelerants for the modification of non-natural amino acids and non-natural amino acid polypeptidesAMBRX INC·Filed 2007·Granted Dec 23, 2008·24 cites·26 claims
- 3294US10702588B2Modified relaxin polypeptides comprising a non-naturally encoded amino acid in the A chainAMBRX INC·Filed 2018·Granted Jul 7, 2020·7 cites·20 claims
- 3394US9975936B2Nucleic acids encoding modified FGF-21 polypeptides comprising non-naturally occurring amino acidsAMBRX INC·Filed 2016·Granted May 22, 2018·12 cites·20 claims
- 3494US9567386B2Therapeutic uses of modified relaxin polypeptidesAMBRX INC·Filed 2013·Granted Feb 14, 2017·14 cites·12 claims
- 3594US9079971B2Modified FGF-21 polypeptides comprising non-naturally occurring amino acidsAMBRX INC·Filed 2013·Granted Jul 14, 2015·19 cites·39 claims
- 3694US7939496B2Modified human growth horomone polypeptides and their usesAMBRX INC·Filed 2005·Granted May 10, 2011·25 cites·4 claims
- 3793US9517273B2Methods of treatment using modified FGF-21 polypeptides comprising non-naturally occurring amino acidsAMBRX INC·Filed 2015·Granted Dec 13, 2016·15 cites·20 claims
- 3893US7959926B2Methods for expression and purification of recombinant human growth hormone mutantsAMBRX INC·Filed 2007·Granted Jun 14, 2011·24 cites·4 claims
- 3992US9962450B2Method of treating heart failure with modified relaxin polypeptidesAMBRX INC·Filed 2016·Granted May 8, 2018·9 cites·21 claims
- 4092US7632823B2Compositions of tRNA and uses thereofAMBRX INC·Filed 2005·Granted Dec 15, 2009·19 cites·43 claims
- 4191US9452222B2Nucleic acids encoding modified relaxin polypeptidesAMBRX INC·Filed 2014·Granted Sep 27, 2016·14 cites·19 claims
- 4288US9586988B2Compositions containing, methods involving, and uses of non-natural amino acids and polypeptidesAMBRX INC·Filed 2013·Granted Mar 7, 2017·4 cites·4 claims
- 4387US2024189392A1Modified Relaxin Polypeptides and Their UsesAMBRX INC·Filed 2023·Application pending·0 cites
- 4486US10961291B2Modified FGF-21 polypeptides and their usesAMBRX INC·Filed 2019·Granted Mar 30, 2021·1 cites·26 claims
- 4586US9637441B2Compositions containing, methods involving, and uses of non-natural amino acids and polypeptidesAMBRX INC·Filed 2014·Granted May 2, 2017·1 cites·24 claims
- 4684US10954270B2Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivativesAMBRX INC·Filed 2017·Granted Mar 23, 2021·2 cites·13 claims
- 4784US10377805B2Modified FGF-21 polypeptides comprising non-naturally encoding amino acids and their usesAMBRX INC·Filed 2018·Granted Aug 13, 2019·2 cites·21 claims
- 4882US9644014B2Modified animal erythropoietin polypeptides and their usesAMBRX INC·Filed 2015·Granted May 9, 2017·3 cites·12 claims
- 4981US11786578B2Modified relaxin polypeptides and their usesAMBRX INC·Filed 2022·Granted Oct 17, 2023·0 cites·19 claims
- 5081US2023028168A1Modified Relaxin Polypeptides and Their UsesAMBRX INC·Filed 2022·Application pending·0 cites
Showing the top 50 of 114 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when AMBRX INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →